Petros Giannikopoulos

2.0k total citations
17 papers, 454 citations indexed

About

Petros Giannikopoulos is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Petros Giannikopoulos has authored 17 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Petros Giannikopoulos's work include Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Petros Giannikopoulos is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Petros Giannikopoulos collaborates with scholars based in United States, Spain and Canada. Petros Giannikopoulos's co-authors include Jung Hoon Lee, Robert A. Hegele, Ann–Hwee Lee, Laurie H. Glimcher, Stephen A. Duncan, Jonathan D. Brown, Jorge Plutzky, Jian Wang, Christopher T. Johansen and Trever G. Bivona and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Petros Giannikopoulos

16 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petros Giannikopoulos United States 8 213 212 157 81 71 17 454
Guohe Song China 10 216 1.0× 91 0.4× 131 0.8× 51 0.6× 113 1.6× 19 471
Hai Li China 9 130 0.6× 110 0.5× 121 0.8× 59 0.7× 41 0.6× 19 356
Shinya Tsurusaki Australia 6 229 1.1× 269 1.3× 65 0.4× 70 0.9× 181 2.5× 10 557
Merima Herac Austria 11 112 0.5× 89 0.4× 130 0.8× 58 0.7× 206 2.9× 23 454
Quentin Bayard France 9 302 1.4× 105 0.5× 105 0.7× 70 0.9× 162 2.3× 13 630
Alessandra Cocomazzi Italy 11 116 0.5× 72 0.3× 106 0.7× 73 0.9× 74 1.0× 17 363
Emma Du United States 12 238 1.1× 55 0.3× 152 1.0× 200 2.5× 134 1.9× 16 586
Nadia Boubekeur France 9 169 0.8× 85 0.4× 200 1.3× 167 2.1× 31 0.4× 11 519
Takahiko Sakaue Japan 10 163 0.8× 95 0.4× 101 0.6× 82 1.0× 37 0.5× 32 377
Fenglin Liu China 17 289 1.4× 338 1.6× 206 1.3× 172 2.1× 36 0.5× 53 801

Countries citing papers authored by Petros Giannikopoulos

Since Specialization
Citations

This map shows the geographic impact of Petros Giannikopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petros Giannikopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petros Giannikopoulos more than expected).

Fields of papers citing papers by Petros Giannikopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petros Giannikopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petros Giannikopoulos. The network helps show where Petros Giannikopoulos may publish in the future.

Co-authorship network of co-authors of Petros Giannikopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Petros Giannikopoulos. A scholar is included among the top collaborators of Petros Giannikopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petros Giannikopoulos. Petros Giannikopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kim, Yoona, Minjung Lee, Rodrigo Sánchez-Bayona, et al.. (2024). AI-assisted clinical summary and treatment planning for cancer care: A comparative study of human vs. AI-based approaches.. Journal of Clinical Oncology. 42(16_suppl). 1523–1523. 2 indexed citations
2.
Cushman‐Vokoun, Allison M., Ryan J. Schmidt, Matthew Hiemenz, et al.. (2023). A Primer on Gene Editing: What Does It Mean for Pathologists?. Archives of Pathology & Laboratory Medicine. 148(5). 515–530. 2 indexed citations
3.
Jackson, Nicole, Han‐Na Kim, Anne L. Wyllie, et al.. (2022). Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults. Clinical Infectious Diseases. 76(7). 1209–1217. 13 indexed citations
4.
Giannikopoulos, Petros & David M. Parham. (2022). Pediatric Sarcomas: The Next Generation of Molecular Studies. Cancers. 14(10). 2515–2515.
5.
Giannikopoulos, Petros & David M. Parham. (2021). Rhabdomyosarcoma: How Advanced Molecular Methods Are Shaping the Diagnostic and Therapeutic Paradigm. Pediatric and Developmental Pathology. 24(5). 395–404. 7 indexed citations
6.
Parham, David M. & Petros Giannikopoulos. (2021). Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020. Pediatric and Developmental Pathology. 24(2). 87–95. 3 indexed citations
7.
Pazarentzos, Evangelos, Petros Giannikopoulos, Gorjan Hrustanovic, et al.. (2015). Oncogenic activation of the PI3-kinase p110β isoform via the tumor-derived PIK3CβD1067V kinase domain mutation. Oncogene. 35(9). 1198–1205. 34 indexed citations
8.
Costa, Carlota, Miguel Angel Molina, Ana Drozdowskyj, et al.. (2014). The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR -Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial. Clinical Cancer Research. 20(7). 2001–2010. 180 indexed citations
9.
Foo, Catherine K., Oscar Westesson, Aleah F. Caulin, et al.. (2014). Clinical validation of a comprehensive cancer genomics analysis for lung cancer patients.. Journal of Clinical Oncology. 32(15_suppl). e22122–e22122. 1 indexed citations
10.
Weissman, Jonathan S., Petros Giannikopoulos, John St. John, et al.. (2013). Integrated genomic analysis by whole exome and transcriptome sequencing of tumor samples from EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p) with acquired resistance to erlotinib.. Journal of Clinical Oncology. 31(15_suppl). 11010–11010. 5 indexed citations
11.
Bivona, Trever G., Petros Giannikopoulos, Carlota Costa, et al.. (2013). Integrated genomic analysis of EGFR-mutant non-small cell lung cancer immediately following erlotinib initiation in patients.. Journal of Clinical Oncology. 31(15_suppl). 11067–11067. 1 indexed citations
12.
Pugh, Trevor J., Jiandong Yang, Lauren Ambrogio, et al.. (2013). Abstract 3806: Progressive biallelic loss of TP53 is associated with progression of pleuropulmonary blastoma initiated by germline loss and somatic mutation of DICER1.. Cancer Research. 73(8_Supplement). 3806–3806. 1 indexed citations
13.
14.
Lee, Jung Hoon, Petros Giannikopoulos, Stephen A. Duncan, et al.. (2011). The transcription factor cyclic AMP–responsive element–binding protein H regulates triglyceride metabolism. Nature Medicine. 17(7). 812–815. 165 indexed citations
15.
Chen, Sharon, et al.. (2009). Prenatal diagnosis of primary pulmonary hypoplasia in fraternal twins. Ultrasound in Obstetrics and Gynecology. 35(1). 113–116. 8 indexed citations
16.
Loukas, Marios, et al.. (2004). A retroesophageal right subclavian artery originating from the left aortic arch -- a case report and review of the literature.. PubMed. 63(1). 141–5. 4 indexed citations
17.
Loukas, Marios, Marek Dąbrowski, Michal J. Kantoch, et al.. (2004). A case report of Noonan's syndrome with pulmonary valvar stenosis and coronary aneurysms.. PubMed. 10(12). CS80–3. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guohe Song Breakdown of academic impact, for papers by Hai Li Breakdown of academic impact, for papers by Shinya Tsurusaki Breakdown of academic impact, for papers by Merima Herac Breakdown of academic impact, for papers by Quentin Bayard Breakdown of academic impact, for papers by Alessandra Cocomazzi Breakdown of academic impact, for papers by Emma Du Breakdown of academic impact, for papers by Nadia Boubekeur Breakdown of academic impact, for papers by Takahiko Sakaue Breakdown of academic impact, for papers by Fenglin Liu
Rankless by CCL
2026